Autophagy enhancer small molecule accelerates Aβ clearance

Item Number: 632
Industry: Therapeutic
Category: Neuroscience / Neurology
Development Stage: Early Stage
Organisation Type: University
Country: South Korea
Patent: Korea, PCT
Business Opportunity: Out-Licensing, Technology Transfer, Collaboration R&D


Our small molecule called MSL-5 can treat an Alzheimer’s disease animal model by enhancing autophagic degradation and Hsp70-dependent proteasomal degradation of Aβ/Tau proteins.


Features & Contact

Sign in and you'll be able to send enquiries about this item, view full details and save it